The knockdown of LCN2 resulted in improvement of PCB-induced lipid and iron accumulation in vitro, suggesting that LCN2 plays a pivotal role in PCB-induced NAFLD/NASH. The gene discussed is LCN2; the disease is metabolic dysfunction-associated steatotic liver disease.